Point-of-Care Testing (POCT) Devices

POCT Devices Elastollan 1195A Fused Deposition Modeling with Bambu Lab A1 mini

The Engineering Challenge: Functional TPU in a Regulated World

For engineers designing next-generation Point-of-Care Testing (POCT) Devices, the material selection and manufacturing process for peripheral components is anything but trivial. These devices operate in demanding environments, from bustling clinics to remote field diagnostics, where reliability is non-negotiable. Components like impact-absorbing bumpers, chemically resistant gaskets, ergonomic grips, and vibration-damping feet are not afterthoughts; they are critical to device integrity, user safety, and diagnostic accuracy. The ideal material must be tough, flexible, and exhibit excellent chemical resistance and compression set. This is where a high-performance thermoplastic polyurethane like BASF Elastollan 1195A enters the equation. With its 95A shore hardness, it offers the perfect balance of rigidity and flexibility, making it a prime candidate for these functional roles.

However, specifying this material is only half the battle. The real challenge, as any seasoned manufacturing engineer knows, lies in processing it. Elastollan 1195A, like many high-performance TPUs, is notoriously difficult to process via Fused Deposition Modeling (FDM). Its two primary characteristics create a perfect storm of print failures. First, it is intensely hygroscopic, acting like a sponge for atmospheric moisture. Printing undried or improperly dried filament results in hydrolysis at the nozzle—a process where water molecules violently turn to steam, creating voids, bubbles, and a foamy texture. This catastrophic failure doesn't just ruin surface finish; it decimates the material's mechanical properties, rendering the part useless. Second, its high viscosity and shear-sensitive nature make it a nightmare for most extruder systems. Bowden-style extruders, with their long filament paths, lack the precise control needed to manage the material's tendency to ooze and string, leading to dimensional inaccuracies and messy, non-functional parts. To combat this, engineers are typically forced to print at agonizingly slow speeds, turning rapid prototyping into a multi-day ordeal of failed prints and constant tuning. This bottleneck is simply unacceptable when navigating the tight timelines of medical device development.

A Process Forged for Compliance: ISO 13485, FDA, and IVDR

In the highly regulated medical device sector, "it looks about right" is a recipe for disaster. Compliance with standards like ISO 13485, FDA 21 CFR Part 820, and the CE IVDR for in-vitro diagnostics is paramount. These frameworks are built on a foundation of process control, validation, and repeatability. A manufacturing process that relies on an operator's "feel" or constant, undocumented tuning is fundamentally incompatible with these requirements. This is where our specialized FDM process for Elastollan 1195A provides a decisive advantage.

ISO 13485 & FDA 21 CFR Part 820: These standards demand a robust Quality Management System (QMS) with a heavy emphasis on design controls, verification, and validation. A key component of this is demonstrating that your manufacturing process is stable and repeatable. Our approach directly addresses this.

1. Documented Pre-Drying Protocol: We don't just "dry" the filament. We execute a validated, documented pre-drying protocol to bring the moisture content of the Elastollan 1195A filament down to the manufacturer-specified level before it ever enters the printer. This critical step is logged and controlled, eliminating hydrolysis as a variable and ensuring the material's intrinsic properties are preserved in the final part.
2. Automated Process Calibration: The Bambu Lab A1 mini is central to our repeatability. Its automated bed leveling, active flow rate compensation, and active vibration compensation systems run before every print batch. This removes operator-to-operator variability and ensures that the first layer, and every subsequent layer, is laid down under the exact same conditions, every single time.
3. Process Validation Support: For your Design History File (DHF), you need to prove that the parts used for verification and validation testing are representative of the final production process. By providing dimensionally consistent, mechanically sound parts from a controlled process, we enable you to perform meaningful V&V activities—from drop testing to seal integrity checks—with confidence. The repeatability we offer means the 20th part produced for a test batch is identical to the first, a cornerstone of process validation.

CE IVDR: The European In Vitro Diagnostic Regulation places stringent requirements on the performance and safety of POCT devices. A device that fails due to a cracked housing or a compromised seal after a minor drop can lead to incorrect diagnoses. Our process allows you to rapidly iterate on designs for components like protective bumpers and gaskets, using the actual end-use material. Printing functional prototypes with Elastollan 1195A allows for early-stage physical testing that directly correlates to the final device's resilience and reliability, significantly de-risking the path to CE marking.

Core Process & Material Specifications

This table outlines the critical parameters that define our capability. We've moved beyond generic FDM specifications to a tightly controlled process window engineered specifically for producing functional Elastollan 1195A components for medical device prototyping.

Cost, Volume, and the Economics of Speed

Our process is optimized for production volumes of 1-20 units. This isn't a limitation; it's a strategic focus. This volume range is the sweet spot for design verification, functional prototyping, and bridge manufacturing while injection molding tools are being prepared. In this phase of product development, speed and reliability are more valuable than pure per-unit cost. The true cost of prototyping isn't just the price on the quote; it's the total cost of engineering time, project delays, and failed iterations. Our service is engineered to minimize this total cost of ownership (TCO).

The core of our factory advantage lies in mastering a difficult material-machine pairing. The Bambu Lab A1 mini, while often seen as a consumer-grade machine, possesses a specific set of features that, when leveraged correctly, make it an industrial powerhouse for this application. Its lightweight direct-drive extruder is the hero of this story. Unlike a heavy direct-drive unit that limits acceleration, or a Bowden setup that introduces hysteresis and lag, the A1 mini's design provides the instantaneous filament control necessary to manage the high back-pressure and viscosity of Elastollan 1195A. This allows for aggressive, yet precise, retractions that effectively eliminate the stringing and oozing that plague other systems. We can start and stop extrusion on a dime, resulting in clean, sharp features.

This mechanical advantage is coupled with our rigorous, documented pre-drying protocol. By systematically removing moisture, we prevent hydrolysis and ensure the material extrudes with a consistent melt viscosity. This consistency allows the A1 mini's automated systems—specifically its active vibration compensation and flow dynamics calibration—to work their magic. The machine's firmware actively compensates for kinematic vibrations at high speeds, allowing us to print at velocities of up to 500 mm/s and accelerations of 10,000 mm/s². This is not a theoretical maximum; it's a practical, repeatable operating speed for this material in our process. The result is a 3-5x reduction in print time compared to a conventionally tuned FDM printer struggling with TPU.

What does this mean for you, the engineer? It means you can submit a design for a complex set of gaskets and bumpers in the morning and have dimensionally accurate, mechanically robust, net-shape functional parts on your desk the next day, not next week. It eliminates the frustrating and costly cycle of receiving a poorly printed part, tweaking the design, and re-ordering, only to find the issue was the manufacturing process, not your model. We have eliminated the extensive tuning and guesswork, delivering a reliable manufacturing service that accelerates your development timeline and gets your POCT device into verification testing faster.

Conclusion: Accelerate Your POCT Development

Stop fighting with TPU. Stop accepting slow, stringy, and dimensionally inaccurate prototypes as the status quo. Leverage our specialized, repeatable, and fast FDM process for Elastollan 1195A to get functional parts that meet the rigorous demands of the medical device industry. Accelerate your design verification and validation cycles with parts you can trust.